All In Biotech

Drug Trial Radar · NCT06612268

A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease

A Global Phase 3, Randomised, Double-blind and Placebo-controlled Study Evaluating the Efficacy and Safety of Etavopivat in Adolescents and Adults With Sickle Cell Disease

Last checked: Nov 20, 2026Latest source record: Sep 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 510 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

510

Planned (sponsor's estimate)

Start

Feb 17, 2025

Primary completion

Aug 27, 2027

Study completion Aug 12, 2029

Sponsor

Lead sponsor
Novo Nordisk A/SNovo Nordisk (NVO)
Sponsor type
Industry
First posted
Sep 25, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 12 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study is conducted to confirm whether etavopivat works well at reducing the number of Vaso-occlusive crisis VOCs (sickle cell pain crises) caused by obstructions in blood vessels in adults and adolescents living with sickle cell disease. The study will also evaluate how well etavopivat can reduce the damage to different organs, improve your exercise tolerance and reduce fatigue in people with sickle cell disease.The participants will either get etavopivat or placebo. Which treatment the participants will get is decided by chance. Etavopivat is a new medicine and is currently being tested in other studies in addition to this one. The study will last for about 2 years.

Conditions

  • Sickle Cell Disease

Interventions

  • EtavopivatDrug

    Etavopivat will be administered orally.

  • PlaceboDrug

    Placebo matching Etavopivat will be administered orally.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of adjudicated Vaso-occlusive crisis (VOC) events with a medical contactTime frame: Baseline (week 0) to week 52

Locations

175 sites in 21 countries. Site status is shown where the registry gives one.

  • Uni of Alabama at Birmingham

    Birmingham, Alabama · Recruiting

  • Univer South Alabama Ped/Onc

    Mobile, Alabama · Recruiting

  • Phoenix Children's Hsptl

    Phoenix, Arizona · Recruiting

  • Arkansas Children's Hospital

    Little Rock, Arkansas · Recruiting

  • Children's Hospital Los Angeles - Endocrinology

    Los Angeles, California · Recruiting

  • UCLA Health

    Los Angeles, California · Completed

  • Valley Children's Hospital

    Madera, California · Recruiting

  • University Of California Irvine

    Orange, California · Completed

  • Stanford University_Palo Alto

    Palo Alto, California · Recruiting

  • Harbor-UCLA Medical Center

    Torrance, California · Recruiting

  • Clinical and Transl Res Center

    Aurora, Colorado · Completed

  • Nemours/AI duPont Hosp-Chld

    Wilmington, Delaware · Recruiting

  • Childrens National Medical Ctr

    Washington D.C., District of Columbia · Recruiting

  • MedStar Hlth Res Institute

    Washington D.C., District of Columbia · Recruiting

  • Memorial Healthcare

    Hollywood, Florida · Recruiting

  • Children's Healthcare Atlanta

    Atlanta, Georgia · Recruiting

  • Childrens Hospital of Chicago

    Chicago, Illinois · Recruiting

  • Univer Of Illinois at Chicago

    Chicago, Illinois · Recruiting

  • Children's Hosp-New Orleans

    New Orleans, Louisiana · Recruiting

  • Boston Children's Hospital

    Boston, Massachusetts · Recruiting

  • Boston Medical Center

    Boston, Massachusetts · Recruiting

  • Henry Ford Hospital_Detroit

    Detroit, Michigan · Completed

  • University of Minnesota

    Minneapolis, Minnesota · Recruiting

  • Washington University-St.Louis

    St Louis, Missouri · Recruiting

  • Children's Nebraska

    Omaha, Nebraska · Recruiting

  • Cure 4 the Kids Foundation

    Las Vegas, Nevada · Completed

  • Newark Beth Israel MC

    Newark, New Jersey · Recruiting

  • NYC Health+Hospitals

    Brooklyn, New York · Recruiting

  • Interfaith Medical Center

    Brooklyn, New York · Recruiting

  • Northwell Health

    Mount Kisco, New York · Completed

  • Cohen Children's Medical Ctr

    Queens, New York · Recruiting

  • Jacobi Medical Center

    The Bronx, New York · Recruiting

  • Montefiore Medical Ctr

    The Bronx, New York · Recruiting

  • Duke Comprehen Sickle Cell

    Durham, North Carolina · Recruiting

  • Duke University Medical Center

    Durham, North Carolina · Recruiting

  • East Carolina Univ-Greenville

    Greenville, North Carolina · Recruiting

  • Atrium Health-Wake Forest Bapt

    Winston-Salem, North Carolina · Recruiting

  • Univ Hosp Cleveland Med Ctr

    Cleveland, Ohio · Recruiting

  • Ohio State Univ Wexner Med Ctr

    Columbus, Ohio · Recruiting

  • Univ of OK Health Sciences Ctr

    Oklahoma City, Oklahoma · Recruiting

Showing 40 of 175 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.